164 related articles for article (PubMed ID: 36511888)
1. Early initiation of treatment with oral propranolol for infantile hemangioma improves success rate.
Léauté-Labrèze C; Frieden I; Delarue A
Pediatr Dermatol; 2023 Mar; 40(2):261-264. PubMed ID: 36511888
[TBL] [Abstract][Full Text] [Related]
2. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
[TBL] [Abstract][Full Text] [Related]
3. Safety of propranolol for infantile hemangioma in infants less than five weeks corrected age.
Gatts JE; Rush MC; Check JF; Samelak DM; McLean TW
Pediatr Dermatol; 2022 May; 39(3):389-393. PubMed ID: 35243678
[TBL] [Abstract][Full Text] [Related]
4. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of oral propranolol for infantile hemangioma in Japan.
Kaneko T; Sasaki S; Baba N; Koh K; Matsui K; Ohjimi H; Hayashi N; Nakano A; Ohki K; Kuwano Y; Morimoto A; Tamaki Z; Kakazu M; Kishi K; Oyama T; Sato A; Kato R; Higuchi T
Pediatr Int; 2017 Aug; 59(8):869-877. PubMed ID: 28453894
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
7. Oral propranolol administration is effective for infantile hemangioma in late infancy: A retrospective cohort study.
Kridin K; Pam N; Bergman R; Khamaysi Z
Dermatol Ther; 2020 May; 33(3):e13331. PubMed ID: 32216160
[TBL] [Abstract][Full Text] [Related]
8. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
[TBL] [Abstract][Full Text] [Related]
9. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
10. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
11. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
Colmenero Sendra M; Del Boz González J; Segura Palacios JM; Valladares Millán I; Eguiluz Solana M; de Troya Martín M
Actas Dermosifiliogr; 2024 Feb; 115(2):215-217. PubMed ID: 37356545
[No Abstract] [Full Text] [Related]
12. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
Kagami S; Kaneko M; Katori T
J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of infantile hemangioma after termination of propranolol treatment.
Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
[TBL] [Abstract][Full Text] [Related]
14. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
15. Low-dose propranolol regimen for infantile haemangioma.
Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
[TBL] [Abstract][Full Text] [Related]
16. Propranolol Therapy for Problematic Infantile Hemangioma.
Ng M; Knuth C; Weisbrod C; Murthy A
Ann Plast Surg; 2016 Mar; 76(3):306-10. PubMed ID: 26010350
[TBL] [Abstract][Full Text] [Related]
17. Immediate possible adverse event rates in infants treated with oral propranolol for infantile haemangiomas at an Australian urban tertiary hospital between 2016 and 2019.
Adams L; Ryan E
Australas J Dermatol; 2022 Nov; 63(4):473-478. PubMed ID: 35938573
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
19. Propranolol Treatment of Vascular Anomalies Other Than Infantile Hemangioma.
Goss JA; Konczyk DJ; Alomari MH; Maclellan RA; Greene AK
J Craniofac Surg; 2017 Nov; 28(8):2001-2003. PubMed ID: 28968329
[TBL] [Abstract][Full Text] [Related]
20. Propranolol for the treatment of orbital infantile hemangiomas.
Fridman G; Grieser E; Hill R; Khuddus N; Bersani T; Slonim C
Ophthalmic Plast Reconstr Surg; 2011; 27(3):190-4. PubMed ID: 21283032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
